These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17214097)

  • 1. A clonal hypereosinophilic syndrome with specific and effective therapy: a report of two cases.
    Ellis MH; Ashur-Fabian O; Trakhtenbrot L; Amariglio N
    Isr Med Assoc J; 2006 Dec; 8(12):836-7. PubMed ID: 17214097
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypereosinophilic syndrome--difficult-to-catch diagnosis. Targeted molecular diagnostics and treatment now possible thanks to gene discovery].
    Jönsson S; Lewerin C; Jacobsson S; Wadenvik H
    Lakartidningen; 2006 Sep 6-12; 103(36):2556-9. PubMed ID: 17007200
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypereosinophilic syndrome: diagnosis and treatment.
    Peros-Golubicić T; Smojver-Jezek S
    Curr Opin Pulm Med; 2007 Sep; 13(5):422-7. PubMed ID: 17940488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of a case of pediatric hypereosinophilic syndrome with anti-interleukin-5.
    Mehr S; Rego S; Kakakios A; Kilham H; Kemp A
    J Pediatr; 2009 Aug; 155(2):289-91. PubMed ID: 19619754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.
    Smith KJ; Jacobson E; Hamza S; Skelton H
    Arch Dermatol; 2004 May; 140(5):584-8. PubMed ID: 15148104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib therapy in Hypereosinophilic Syndrome: a case of molecular remission.
    Cervetti G; Galimberti S; Carulli G; Petrini M
    Leuk Res; 2005 Sep; 29(9):1097-8. PubMed ID: 16038739
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic eosinophilic leukemia presenting with mouth and penile ulcers.
    Najera JE; Harn L
    Am J Med; 2012 Aug; 125(8):e5-6. PubMed ID: 22681908
    [No Abstract]   [Full Text] [Related]  

  • 8. [A man with FIP1L1/PDGFRA-positive chronic eosinophilic leukemia].
    Leeksma OC; de Ruiter GS; van der Hulst VP; Terpstra WE; Cools J; Vandenberghe P
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1936-43. PubMed ID: 16999279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glivek in the therapy of some forms of Ph- and bcr/abl-negative myeloproliferative diseases and a myeloproliferative variant of idiopathic hypereosinophilic syndrome].
    Nemchenko IS; Khoroshko ND; Turkina AG; Vinogradova OIu; Sokolova MA; Abakumov EM; Semenova EA; Zakharova AV; Domracheva EV
    Ter Arkh; 2004; 76(7):87-90. PubMed ID: 15379136
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genetic mutations and molecularly-targeted drugs in hypereosinophilic syndromes].
    Yamada Y
    Arerugi; 2011 Feb; 60(2):167-77. PubMed ID: 21399396
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate.
    Garg A; Duggal L; Aggarwal S; Jain N
    J Assoc Physicians India; 2006 Nov; 54():883-6. PubMed ID: 17249259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The hypereosinophilic syndrome: case report].
    Mikołajczyk K; Zaba R; Walkowiak B; Grzybowski G; Samborski W
    Ann Acad Med Stetin; 2006; 52 Suppl 2():65-9. PubMed ID: 17471838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of idiopathic hypereosinophilic syndrome with imatinib].
    Sørensen AL; Larsen H
    Ugeskr Laeger; 2008 Jan; 170(4):254. PubMed ID: 18282461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib-mesylate for all patients with hypereosinophilic syndrome?
    Musto P; Perla G; Minervini MM; Carella AM; Coco FL; Catalano G
    Leuk Res; 2004 Jul; 28(7):773-4. PubMed ID: 15158099
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypereosinophilic syndrome in childhood: clinical and molecular features of two cases.
    Farruggia P; D'Angelo P; Acquaviva A; Trizzino A; Tucci F; Cilloni D; Messa F; D'Ambrosio A; Aricò M
    Pediatr Hematol Oncol; 2009; 26(3):129-35. PubMed ID: 19382034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic cholangiopathy with concurrent eosinophilic colitis in a patient with idiopathic hypereosinophilic syndrome.
    Sussman DA; Bejarano PA; Regev A
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):574-7. PubMed ID: 18467919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Practical approach to hypereosinophilia].
    Roufosse F; Cogan E
    Rev Med Brux; 2008 Sep; 29(4):400-8. PubMed ID: 18949995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with imatinib mesylate of hypereosinophilic syndrome (chronic eosinophilic leukemia) with myelofibrosis.
    Ishii Y; Ito Y; Kuriyama Y; Tauchi T; Ohyashiki K
    Leuk Res; 2004 May; 28 Suppl 1():S79-80. PubMed ID: 15036947
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypereosinophilic syndrome: two case reports of contrasting variants.
    Szymanski J; Rappaport E
    South Med J; 2005 Apr; 98(4):467-8. PubMed ID: 15898525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term experience with imatinib therapy in chronic phase chronic myelogenous leukemia--remarkable activity with room for improvement.
    Tefferi A; Kantarjian H
    Am J Hematol; 2008 Mar; 83(3):175-7. PubMed ID: 18181199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.